S
taging of dementia allows better management of the clinical condition and can help reduce caregiver dependency and burden. 1, 2 Dementia severity assessment scales can be more suitable for monitoring the course of symptoms of neurodegenerative diseases than brief cognitive assessment measures, such as the Mini-Mental State Exam (MMSE), or neuropsychological assessment. 3 However, scales for staging dementia were developed based on symptoms of Alzheimer disease (AD) and are potentially less sensitive to the progression observed in other dementias. 4 Currently, the most widely used dementia staging scale worldwide is the Clinical Dementia Rating (CDR). 5, 6 This is a semistructured interview performed with both patient and caregiver that collects information on 6 functional domains (memory, orientation, judgment and problem solving, community affairs, home and hobbies, and personal care). Each domain is rated as 0, 0.5, 1, 2, and 3, where higher scores indicate worse functioning in the domain. All the domains taken together yield a global CDR score also ranging from 0 to 3, 5 with 0 indicating no impairment, 0.5 questionable impairment, 1.0 mild impairment, 2.0 moderate impairment, and 3.0 severe impairment.
More recently, a CDR version was devised that includes 2 additional domains that are often impaired in frontotemporal dementia (FTD), namely, language and behavior, forming the Clinical Dementia Rating Scale for Frontotemporal Lobar Degeneration (CDR-FTLD). 7 These new domains provide information on the specific symptoms of the variants of FTD, that is, the primary progressive aphasias (PPA) and behavioral variant frontotemporal dementia (bvFTD), which can significantly impact severity assessment of these conditions. 8 In other words, individuals with FTD may be defined as having questionable or mild impairment on the CDR in the absence of assessment of these additional domains.
Given the need to develop specific instruments for staging typical symptoms of FTD variants, Mioshi et al 4 developed the Frontotemporal Dementia Rating Scale (FTD-FRS). The FTD-FRS was structured based on the questions from the Disability Assessment For Dementia (DAD) functional scale 9 and the Cambridge Behavioral Inventory (CBI), 10, 11 producing a 75-item questionnaire covering behavioral disorders and functional disability. The new instrument was applied in a sample of 77 FTD patients (behavioral variant = 29; semantic variant = 28; nonfluent variant = 20), matched for age and length of symptoms. After analysis of the psychometric characteristics and construct validity for staging the dementia condition, the scale was shortened to 30 items.
In the study by Mioshi et al, 4 6 stages of severity were identified by the scale (very mild, mild, moderate, severe, very severe, and advanced/profound). The FTD-FRS was capable of detecting functional deterioration in the 3 clinical variants of FTD over 12 months. The decline in FTD-FRS over this period was found to differ across the FTD subtypes, where bvFTD progressed the most rapidly. Lastly, the scale was useful for assessing progression given that length of behavioral symptoms and global cognitive assessments, alone, do not reflect severity in FTD. The internal consistency with Cronbach α was 0.93 and stability on the test-retest was 0.994, suggesting good psychometric characteristics.
Turró-Garriga et al 12 carried out the translation and adaptation of the FTD-FRS into Spanish. The authors recruited 82 patients, comprising 60 with bvFTD and 22 with AD. The Spanish-language version of the FTD-FRS displayed good internal consistency (α = 0.897) and strong correlation with the MMSE, DAD, and CDR. The severity of dementia was rated as more severe by the FTD-FRS than by the CDR.
The FTD-FRS has been translated and adapted into Portuguese for use in Brazil. After back-translation, pilot application, and assessment by specialist judges, the final version of the scale was produced. 13 Application of this version of the FTD-FRS in a pilot study suggested the scale is adequate for use in Brazil. However, no studies assessing the validity of the Brazilian version of the scale have been conducted. Therefore, the objective of the present study was to examine the factor structure, internal consistency, temporal stability, and convergent validity with the MMSE and CDR-FTLD.
METHODS
This is a cross-sectional analysis based on the initial dataset of a clinical study including healthy controls (HC), bvFTD, AD, PPA, and mild cognitive impairment (MCI) patients.
Participants
Databases from university-based neurology outpatient services were examined and patients and their caregivers were invited to take part in the study, at the following institutions: Cognitive and Behavioral Neurology Group (GNCC-SP) and Program for the Elderly (PROTER) at the University of São Paulo; Cognitive and Behavioral Neurology Group (GNCC-MG) at the Federal University of Minas Gerais, and the Department of Neurology at the State University of Campinas (UNICAMP). HC participants were recruited from an Open University for the elderly.
The diagnosis of dementia was performed by neurologists, geriatricians, and psychiatrists, based on clinical and cognitive assessments along with laboratory and neuroimaging exams. Dementia was diagnosed based on the criteria from the Diagnostic and Statistical Manual 5th Edition (DSM-V). 14 International diagnostic criteria were employed for diagnosing probable bvFTD. 1, 15 The National Institute on Aging-Alzheimer's Association-NIA/AA criteria were used for AD diagnosis. 16, 17 Patients at mild and moderate stages (CDR, 0.5 to 2.0) of bvFTD 1 and AD 5, 6 were selected. The criteria recommended by Gorno-Tempini et al 18 were used for diagnosing semantic and nonfluent variants of FTD. MCI (amnestic and nonamnestic) were diagnosed based on the criteria of Albert et al. 19 Inclusion criteria for patients were age above 40 years, education > 2 years and presence of an informant who was involved in the daily routine of the patient (formal or informal caregiver, spending at least 8 h/d with the patient). Individuals presenting with visual, auditory, or motor deficits preventing them from understanding instructions or performing cognitive tasks; individuals with other uncontrolled clinical diseases (such as hypertension and diabetes); serious and debilitating psychiatric disorders such as major depression, schizophrenia, bipolar disorder; clinical evidence or neuroimaging exam findings suggestive of vascular problems; dementias or etiologies other than FTD or AD, were excluded.
For the control group, participants that were illiterate, scored > 5 on the Geriatric Depression Scale 20 or whose performance on the MMSE was below the cut-off point for dementia 21 were excluded. The following cut-off points were adapted for educational level: 1 to 4 years of education, 22 points; 5 to 8 years, 24 points; > 8 years, 26 points. These cut-off scores were adapted from Brucki et al 21 based on the mean for each educational band minus 1 SD. In addition, subjects exhibiting functional changes suggestive of dementia on the Functional Activities Questionnaire (FAQ > 2) 22, 23 were also excluded.
Caregivers included in the study were mostly women, with mean age of 54.1 (SD ± 15.4) and mean educational level of 12.9 (SD ± 3.8).
Instruments

Patient Protocol
A questionnaire collecting sociodemographic and clinical data including age, income, years of education, marital status, general health status, presence of other clinical disease, and use of medications was applied. This block of the protocol was applied to controls and caregivers of dementia patients.
Cognitive assessment. The Addenbrooke's Cognitive Examination-Revised ACE-R 24,25 was used and provided scores for the MMSE. The maximum score is 100 points, distributed among the domains: attention and orientation (18) , memory (35), verbal fluency (14), language (28) , and visual-spatial ability (5). The cut-off point for dementia on the battery is 78 points (Brazilian version). 25 
Family Member/Companion Protocol
Functional Assessment. The FAQ is based on an indirect assessment of patient functioning. The scale comprises 10 items that investigate the degree of independence for performing activities of daily living. The minimum score is 0 and maximum 30 points where higher scores indicate greater degree of dependency of the patient. 22, 23 Dementia staging scales. The CDR-FTLD version adapted by Knopman et al 1 was used. This version of the scale includes the assessment of the domains of memory, orientation, judgment and problem solving, community affairs, home and hobbies, and personal care from the original, plus the domains of language and behavior. Part of the assessment is performed with the patient while a complementary semistructured interview is conducted with their companion. On the basis of the data collected, the clinician rates each domain with scores of 0, 0.5, 1, 2, and 3, and finally provides a global rating of the patient's cognitive status using this same rating scale for total score. The CDR-FTLD sum of boxes scores was also employed in this study.
The FTD-FRS assesses the domains: behavior, outing and shopping, household chores (use of telephone, finances, medications, and meal preparation), self-care, and mobility. Response options for each question are: all the time = 0; sometimes = 0 and never = 1. The "never" answers are tallied and divided by the number of questions (range, 0 to 30) answered by the interviewee, multiplied by 100 (number of "never" responses/number of questions answered×100) to give a score in percent, with using a logarithm Table indicating the disease stage of the patient. 4, 13 A total raw score of 30 is obtained, which is then converted into a logit score that ranges from 5.39 (normal) to −6.66 (advanced/profound impairment). The score indicates 6 stages of severity: very mild, mild, moderate, severe, very severe, and advanced/profound.
The Brazilian version of FTD-FRS was generated after a translation and cross-cultural adaptation processes which consisted of the following steps: translation, back-translation (prepared by independent translators), evaluation of the back-translated version against the original version, discussion of the Portuguese version of the FTD-FRS with specialists, development of a final version after minor adjustments, and pilot application in patients with a diagnosis of bvFTD and AD. This procedure was described in detail in a previous study. 13 
Procedures
Data collection took place at the research centers involved, in a room reserved for this purpose offering suitable lighting and acoustic conditions. Application of the protocol took around 60 minutes for patients and 45 minutes for healthy subjects. The interview with informants took around 45 minutes. The protocol was applied by previously trained examiners.
Ethical Aspects
This study was approved by the Ethics Committee for Analysis of Research Projects (CAPPesq) of the Medical Board of the Clínicas Hospital and of the University of São Paulo School of Medicine, permit 311.601. All participants and their caregivers signed the Free and Informed Consent Form (TCLE) and were given explanations on the study procedures. The study was conducted in compliance with International ethics standards (Declaration of Helsinki).
Statistical Analyses
The
The data from the 97 participants for the 30 items of the FTD-FRS were submitted to Exploratory Factor Analysis using the common factor model. This model holds that the variance observed in each measurement can be attributed to a relatively small number of common factors (ie, common characteristics not observable in ≥ 2 variables) and to a single specific factor (not related with any other underlying factor from the model). Thus, the aim of exploratory factor analysis, with a common factor model, is to identify the common factors (separate from specific factors) and explain their relationship with the data observed. Varimax rotation was chosen in order to maximize the power of discrimination among the factors.
In addition, Cronbach α coefficient was calculated to analyze the internal consistency of the FTD-FRS and its domains. In a subsample of 22 healthy control subjects, temporal stability was tested by comparing FTD-FRS scores obtained in 2 applications (test and retest) with an interval of approximately 2 months (M, 7.2 wk; SD, 1.8), using 2-way mixed intraclass correlation coefficient with absolute agreement.
The data were keyed into Version 3.1 of the Epidata Program. All statistical analyses were performed using the SPSS v.17.0 and Statistica v.7.0 software packages. The level of significance adopted for the statistical tests was 5%, (ie, a P-value < 0.05).
RESULTS
Sociodemographic and Clinical Data of the Studied Sample
A total of 97 individuals, comprising 31 diagnosed with bvFTD, 8 with PPA (semantic variant, n = 3; nonfluent variant, n = 5), 28 with AD, and 8 with MCI, and a control group of 22 healthy subjects. Family members or caregivers who had frequent contact with the patient also took part. The patients with bvFTD and with AD had equivalent disease severity on the CDR-FTLD. The sociodemographic and clinical characteristics of the sample are given in Table 1 . Patients with AD and PPA had worse performance on the MMSE and ACE-R relative to participants of the other groups.
Scores on the CDR-FTLD and FTD-FRS for the groups are given in Table 2 . A significant difference was found among the groups on the CDR-FTLD and FTD-FRS, indicating greater severity in patients diagnosed with bvFTD.
Indicators of Construct Validity
In order to achieve one of the objectives of the study, Bartlett test of Sphericity and the Kaiser-Meyer-Olkin (KMO) test were performed. The results indicated correlation among the items assessed on the FTD-FRS (χ 2 [df = 435] = 2261.91; P < 0.001) and sampling adequacy (KMO, 0.715), respectively, for performing the exploratory factor analysis below.
The exploratory factor analysis (with Varimax rotation) of the FTD-FRS revealed the existence of four factors, with eigenvalues > 1, which together explained 77.13% of the total variance with values from 1.28 to 17.52 (see Table 3 ).
The factor loadings matrix (ie, the matrix whose values are the correlations among the original variables and common factors) for the 4-factor solution is given in Appendix A (Supplemental Digital Content, http://links.lww.com/WAD/ A195). The criteria for belonging to the factor was having a loading ≥ 0.50. 26, 27 Factor 1 is associated with behavior, factor 2 self-care and mobility, factor 3 meal preparation, and factor 4 to outings and shopping, household chores, finances and medications.
The results of the analysis of the internal consistency of the factors found are given in Table 4 . The overall instrument and each factor exhibited high consistency ( > 0.90) and the removal of items with lower factor loadings was not beneficial since it reduced the coefficients. The analysis of temporal stability yielded a κ index of 0.97 (P-value < 0.001) suggesting high stability. 26, 27 
Convergent Validity of the FTD-FRS With the CDR-FTLD
Correlations of the factors of the FTD-FRS with the subdomains of the CDR-FTLD scale are given in Table 5 . The 4 proposed domains of the FTD-FRS showed significant correlations with the subdomains of the CDR-FTLD scale. 
DISCUSSION
The objective of the present study was to examine the factor structure, internal consistency, temporal stability, and convergent validity of the Brazilian version of the FTD-FRS. This is the first study that carried out an exploratory factorial analysis of the items composing the FTD-FRS. It is also the first to perform a convergent validation analysis with the CDR-FTLD and another scale specific for dementia staging for the DFT spectrum.
Clinical Findings
Descriptive analyses suggested the CDR-FTLD seemed to underestimate the severity of dementia in bvFTD, as a substantial proportion of the patients rated as mild on the scale (CDR, 1.0) had moderate or severe impairment according to the FTD-FRS. This finding supports recent evidence that the FTD-FRS may capture subtle changes associated with disease progression 4 that may not be observed when the original CDR is used. 4, 13 However, in a more recent study, 8 the CDR-FTLD, which includes language and behavior domains, was also shown to be sensitive for documenting decline in patients with FTD, but a direct comparison between the FTD-FRS and the CDR-FTLD is yet to be conducted.
In a previous imaging study, 28 where the CDR-FTLD and FTD-FRS were correlated with brain perfusion in patients diagnosed with FTD, both scales were predictors of frontal lobe perfusion in the bvFTD patient group and predictors of temporal hypoperfusion in the PPA group. In the study, the authors considered the scales adequate for documenting severity in FTD.
Psychometric Characteristics of the FTD-FRS
In the original FTD-FRS design and validation study, 4 the authors aimed to divide the questions by domains to facilitate their application in clinical practice. The scale in its original form contains 30 items organized into 7 domains.
The current exploratory factor analysis of the FTD-FRS identified the possibility of reducing the number of domains to 4. In this new format, the first domain or factor 1, with 6 items (factor loadings of 0.67 to 0.81) is associated with behavior changes. The second domain or factor 2, with 4 items (factor loadings of 0.81 to 0.85), is related to self-care and mobility. The third domain or factor 3, comprising 8 items (factor loadings of 0.60 to 0.87), is linked to meal preparation. Lastly, the fourth domain or factor 4, comprising 12 items (factor loadings of 0.50 to 0.81), relates to outings and shopping, household chores, finances, and medications. The high eigenvalues observed in the scale domains may reflect the behavioral changes of the sample which impact the basic and instrumental activities of daily living, 26, 27 contemplated in FTD-FRS items. 4, 12, 13 The 4 observed domains of the FTD-FRS correlated with the domains of the CDR-FTLD, consistent with a previous study. 12 These results indicate the convergent validity of the Brazilian version of the scale, according to the present exploratory factor analysis.
The results for the internal consistency and reliability on the test-retest analyses suggested construct validity and temporal stability, congruent with the previous findings. 4, 12 The FTD-FRS is a recent scale and hence there are few studies investigating its psychometric characteristics. The present study is the first to document the factorial structure of the FTD-FRS and its convergent validity with the CDR-FTLD. These tools are key to determine dementia severity in FTD variants.
Determining disease severity in dementia, and especially in less prevalent subtypes, is still a controversial issue. There is currently a lack of consensus regarding the definition of severity in dementia and its ideal staging tools. 29 Cognitive-based staging strategies are limited, since they are heavily dependent on language skills, which might overestimate disease severity, as observed in PPAs. 30 In addition, in developing countries, cutoff 12 The present study has some limitations, including the fact that the sample studied was derived from a specialized outpatient clinic for cognitive disorders in adults and elderly and may possibly have contained a high proportion of individuals with specific needs or more severe symptoms. This might have introduced biases that could reduce the generalizability of results to other populations.
In summary, the results suggest that the Brazilian FTD-FRS has satisfactory psychometric properties for clinical use. This instrument may aid in characterizing clinical symptoms relevant for diagnosis and disease staging. It may also document intervention-related outcomes. This study provides clinicians and researchers with a valid instrument with which to classify and follow up on patients diagnosed with FTD. The drafting of a severity scale adapted to the symptoms typical of FTD may facilitate early identification of these conditions and reduce delays between symptom onset and diagnosis. It would also aid in the selection and use of drug treatments, and implementing care. The FTD-FRS is a tool able to improve clinical attention to patients (and their family members), whether in the initial or terminal stages of FTD.
